Study finds trend toward benefit in using blood-clotting agent for bleeding stroke

(American Heart Association) There are few treatment options for bleeding stroke.There was a trend towards reduced growth of brain bleeds in those treated with the antifibrinolytic agent tranexamic acid within 4.5 hours of stroke onset, compared to those treated with placebo.